Emily Gombosi, DPM
Foot Surgery · Geneva, NYNPI 1518455575
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,800 of the $5,865 with a category attached, or 81.8%. 8 manufacturers reported payments, led by Novus Surgical Solutions LLC at 45.0% of the total. Reporting peaked in 2021 at $2,878 and has fallen 99.5% since, to $15 in 2025. Among foot surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $234.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novus Surgical Solutions LLC$3K
- Prodigy Surgical Distribution, Inc.$2K
- Novus Surgical Consultants$281
- Smith+Nephew$227
- Stryker$157
- Arthrex$93
- plus $67 from 2 others
What the payments were for
- Travel & lodging$2584%
- Food & beverage$80714%
- Education$4,80082%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novus Surgical Solutions LLC | 5 | $2,640 |
| Prodigy Surgical Distribution, Inc. | 2 | $2,400 |
| Novus Surgical Consultants | 2 | $281 |
| Smith+Nephew | 8 | $227 |
| Stryker | 2 | $157 |
| Arthrex | 3 | $93 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Integra Lifesciences Corporation | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VARIAX$121
How this compares
$5,865 in reported general payments places this provider in the 90th percentile of 294 foot surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 127 | $2,640 |
| Ciclopirox | 41 | $1,500 |
| Ketoconazole | 58 | $801 |
| Clotrimazole | 23 | $318 |
| Cephalexin | 25 | $109 |
| Terbinafine Hcl | 17 | $107 |
| Meloxicam | 31 | $53 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Geneva
- Ronald GubermanRidgewood$337K
- John JackaloneBethpage$66K
- David WongBronx$45K
- Berdj StepanianWhite Plains$26K
- Lawrence SantiBrooklyn$25K
- David GitlinBayside$24K
- Rick DelmonteNew York$21K
- Corrine RenneFranklin Square$20K
- Charles MorelliMamaroneck$18K
- Evan BrethBrooklyn$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.